Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

Sureda A Peggs KS; UK and Spanish Collaborative Groups; Jorge Sierra Gil

doi:10.1111/j.1365-2141.2011.08785.x

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

Sureda A Peggs KS, UK and Spanish Collaborative Groups, Jorge Sierra Gil

Department of Medicine

Research output: Contribution to journal › Article › Research

48 Citations (Scopus)

Original language	English
Pages (from-to)	70-80
Journal	Br J Haematol
Volume	139
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-2141.2011.08785.x
Publication status	Published - 1 Oct 2007

Access to Document

10.1111/j.1365-2141.2011.08785.x

Cite this

@article{97f10dc61de54428a78ed327ca39c42a,

title = "Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.",

author = "{Peggs KS}, {Sureda A} and Groups, {UK and Spanish Collaborative} and {Sierra Gil}, Jorge",

year = "2007",

month = oct,

day = "1",

doi = "10.1111/j.1365-2141.2011.08785.x",

language = "English",

volume = "139",

pages = "70--80",

number = "1",

}

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. / Peggs KS, Sureda A; Groups, UK and Spanish Collaborative; Sierra Gil, Jorge.

In: Br J Haematol, Vol. 139, No. 1, 01.10.2007, p. 70-80.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

AU - Peggs KS, Sureda A

AU - Groups, UK and Spanish Collaborative

AU - Sierra Gil, Jorge

PY - 2007/10/1

Y1 - 2007/10/1

U2 - 10.1111/j.1365-2141.2011.08785.x

DO - 10.1111/j.1365-2141.2011.08785.x

M3 - Article

VL - 139

SP - 70

EP - 80

IS - 1

ER -